324 related articles for article (PubMed ID: 31455274)
41. Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker.
Erbes T; Hirschfeld M; Rücker G; Jaeger M; Boas J; Iborra S; Mayer S; Gitsch G; Stickeler E
BMC Cancer; 2015 Mar; 15():193. PubMed ID: 25886191
[TBL] [Abstract][Full Text] [Related]
42. Circulating miR-214-3p predicts nasopharyngeal carcinoma recurrence or metastasis.
Wang J; Xu Y; Wang J; Ying H
Clin Chim Acta; 2020 Apr; 503():54-60. PubMed ID: 31926154
[TBL] [Abstract][Full Text] [Related]
43. Identification of dysregulated serum miR-508-3p and miR-885-5p as potential diagnostic biomarkers of clear cell renal carcinoma.
Liu S; Deng X; Zhang J
Mol Med Rep; 2019 Dec; 20(6):5075-5083. PubMed ID: 31661117
[TBL] [Abstract][Full Text] [Related]
44. Serum microRNA microarray analysis identifies miR-4429 and miR-4689 are potential diagnostic biomarkers for biliary atresia.
Dong R; Shen Z; Zheng C; Chen G; Zheng S
Sci Rep; 2016 Feb; 6():21084. PubMed ID: 26879603
[TBL] [Abstract][Full Text] [Related]
45. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
[TBL] [Abstract][Full Text] [Related]
46. Discovery and prevalidation of salivary extracellular microRNA biomarkers panel for the noninvasive detection of benign and malignant parotid gland tumors.
Matse JH; Yoshizawa J; Wang X; Elashoff D; Bolscher JG; Veerman EC; Bloemena E; Wong DT
Clin Cancer Res; 2013 Jun; 19(11):3032-8. PubMed ID: 23575476
[TBL] [Abstract][Full Text] [Related]
47. Microarray analysis of microRNA expression in peripheral blood mononuclear cells of critically ill patients with influenza A (H1N1).
Song H; Wang Q; Guo Y; Liu S; Song R; Gao X; Dai L; Li B; Zhang D; Cheng J
BMC Infect Dis; 2013 Jun; 13():257. PubMed ID: 23731466
[TBL] [Abstract][Full Text] [Related]
48. Discovery and Validation of Salivary Extracellular RNA Biomarkers for Noninvasive Detection of Gastric Cancer.
Li F; Yoshizawa JM; Kim KM; Kanjanapangka J; Grogan TR; Wang X; Elashoff DE; Ishikawa S; Chia D; Liao W; Akin D; Yan X; Lee MS; Choi R; Kim SM; Kang SY; Bae JM; Sohn TS; Lee JH; Choi MG; Min BH; Lee JH; Kim JJ; Kim Y; Kim S; Wong DTW
Clin Chem; 2018 Oct; 64(10):1513-1521. PubMed ID: 30097497
[TBL] [Abstract][Full Text] [Related]
49. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
[TBL] [Abstract][Full Text] [Related]
50. Serum-based six-miRNA signature as a potential marker for EC diagnosis: Comparison with TCGA miRNAseq dataset and identification of miRNA-mRNA target pairs by integrated analysis of TCGA miRNAseq and RNAseq datasets.
Sharma P; Saraya A; Sharma R
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e289-e301. PubMed ID: 29380534
[TBL] [Abstract][Full Text] [Related]
51. Candidate pathways and genes for nasopharyngeal carcinoma based on bioinformatics study.
Chen J; Yang R; Zhang W; Wang Y
Int J Clin Exp Pathol; 2015; 8(2):2026-32. PubMed ID: 25973099
[TBL] [Abstract][Full Text] [Related]
52. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
53. Circulating microRNA expression profiling and bioinformatics analysis of dysregulated microRNAs of patients with coronary artery disease.
Zhong Z; Hou J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
Medicine (Baltimore); 2018 Jul; 97(27):e11428. PubMed ID: 29979444
[TBL] [Abstract][Full Text] [Related]
54. Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data.
Wang YW; Zhang W; Ma R
Oncol Rep; 2018 Mar; 39(3):1003-1010. PubMed ID: 29328395
[TBL] [Abstract][Full Text] [Related]
55. A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer.
Zhao H; Shen J; Medico L; Wang D; Ambrosone CB; Liu S
PLoS One; 2010 Oct; 5(10):e13735. PubMed ID: 21060830
[TBL] [Abstract][Full Text] [Related]
56. MicroRNAs in Salivary Exosome as Potential Biomarkers of Aging.
Machida T; Tomofuji T; Ekuni D; Maruyama T; Yoneda T; Kawabata Y; Mizuno H; Miyai H; Kunitomo M; Morita M
Int J Mol Sci; 2015 Sep; 16(9):21294-309. PubMed ID: 26370963
[TBL] [Abstract][Full Text] [Related]
57. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.
Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J
Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472
[TBL] [Abstract][Full Text] [Related]
58. Identification of key genes, MicroRNAs and potentially regulated pathways in alcoholic hepatitis by integrative analysis.
Yao J; Cheng Y; Zhang D; Fan J; Zhao Z; Li Y; Jiang Y; Guo Y
Gene; 2019 Dec; 720():144035. PubMed ID: 31404595
[TBL] [Abstract][Full Text] [Related]
59. MicroRNAs in urine as diagnostic biomarkers for multiple myeloma.
Li J; Wang C; Meng Q; Hu Z; Hu M; Zhang M
Int J Lab Hematol; 2021 Apr; 43(2):227-234. PubMed ID: 33068078
[TBL] [Abstract][Full Text] [Related]
60. Analysis of serum genome-wide microRNAs for breast cancer detection.
Wu Q; Wang C; Lu Z; Guo L; Ge Q
Clin Chim Acta; 2012 Jul; 413(13-14):1058-65. PubMed ID: 22387599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]